Submitted by Anonymous (not verified) on 19 August 2026 - 16:44
Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation: 15/09/2023, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, Date of authorisation: 15/09/2023, Revision: 6, Status: Authorised